Neuropharmacological studies on Fusarium toxins--II: Total toxin extract from F. oxysporum.
The neuropharmacological activity profile of total fungal extract of F. oxysporum (FO) was investigated. FO enhanced spontaneous locomotor activity, exploratory behaviour and reduced pentobarbitone hypnosis. It had per se anticonvulsant action against maximal electroshock seizure (MES) and potentiated phenobarbitone and phenytoin in MES and also potentiated pentylenetetrazol (PTZ) convulsion. It antagonised morphine, tetrabenazine and haloperidol catalepsy. FO did not show per se analgesia or potentiation of morphine antinociception in mice, while both effects were present in rats. The effect of FO on body temperature was complex. It produced per se reduction in rectal temperature and potentiated the hypothermic responses of reserpine, apomorphine, PEA and I-dopa, and also the hyperthermic response of 5-HTP. The hyperthermic response of haloperidol was reversed by FO. It potentiated amphetamine and morphine lethality, amphetamine, PEA and apomorphine stereotypy, 5-HTP headtwitch response and post-swim grooming response. On swim-stress immobility, while the time of onset of immobility was reduced, FO did not modify the duration of immobility. On foot-shock induced aggression in paired rats, FO produced a decrease in the latency to onset of fighting behaviour and increased the total contact period and the cumulative aggressive score. FO potentiated clonidine automutilation. It has, thus, facilitated aggressive behaviour. The effects are likely to be due to the presence of fusaric acid in FO, which inhibits dopamine beta-hydroxylase and is known to have dopaminergic effects. This investigation has practical implications. since F. oxysporum is a common food contaminant.
Ganguli
S
S
Department of Pharmacology, Banaras Hindu University, Varanasi, India.
Hota
D
D
Goel
R K
RK
Acharya
S B
SB
Bhattacharya
S K
SK
D000700:Analgesics / Q000494:pharmacology; D000818:Animals; D000927:Anticonvulsants / Q000494:pharmacology; D001522:Behavior, Animal / Q000187:drug effects*; D005260:Female; D005669:Fusaric Acid / Q000302:isolation & purification / Q000494:pharmacology / Q000633:toxicity; D005670:Fusarium / Q000737:chemistry*; D008297:Male; D051379:Mice; D009183:Mycotoxins / Q000302:isolation & purification* / Q000494:pharmacology / Q000633:toxicity*; D051381:Rats
D000700:Analgesics; D000927:Anticonvulsants; D009183:Mycotoxins; D005669:Fusaric Acid